27 results on '"Sonn, Geoffrey A"'
Search Results
2. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy for Prediction of Final Prostate Pathology
3. Targeted Prostate Biopsy to Select Men for Active Surveillance: Do the Epstein Criteria Still Apply?
4. Editorial Comment
5. CHANGING UTILIZATION OF PARTIAL NEPHRECTOMY: ARE AT RISK PATIENTS BEING LEFT BEHIND?: MP41-03
6. PROSTATE CANCER YIELD IN MRI LESIONS VARIES ACROSS RADIOLOGISTS: MP05-15
7. Gleason 6 Prostate Cancer: Translating Biology into Population Health
8. MP84-02 DIFFERING KIDNEY FUNCTION OUTCOMES FOLLOWING KIDNEY CANCER SURGERY IN THE VETERANS HEALTH ADMINISTRATION
9. Differing Perceptions of Quality of Life in Patients With Prostate Cancer and Their Doctors
10. Optical Biopsy of Human Bladder Neoplasia With In Vivo Confocal Laser Endomicroscopy
11. Targeted Prostate Biopsy in Select Men for Active Surveillance—Do the Epstein Criteria Still Apply?
12. MRI-US FUSION BIOPSY FOR IMPROVED PREDICTION OF WHOLE-ORGAN PROSTATE PATHOLOGY: MP46-03
13. TARGETED BIOPSY WITH MRI-ULTRASOUND FUSION: V1267
14. Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion Device
15. Differing Perceptions of Quality of Life in Patients With Prostate Cancer and Their Doctors
16. ANTITUMOR ACTIVITY OF SUNITINIB VERSUS OTHER FDA-APPROVED TARGETED CANCER AGENTS AGAINST METASTATIC RENAL CELL CARCINOMA IN THE FIRST-LINE SETTING: 2003
17. NON-CLEAR CELL HISTOLOGY IS INDEPENDENTLY ASSOCIATED WITH POOR OUTCOMES IN THE TARGETED THERAPY ERA: 2002
18. UISS RISK STRATIFICATION CAN IDENTIFY PATIENTS LESS LIKELY TO BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: 979
19. ESTIMATING THE RISK OF CANCER ASSOCIATED WITH IMAGING-RELATED RADIATION DURING SURVEILLANCE FOR STAGE I TESTICULAR CANCER USING COMPUTED TOMOGRAPHY: 909
20. Editorial Comment
21. MP46-03 MRI-US FUSION BIOPSY FOR IMPROVED PREDICTION OF WHOLE-ORGAN PROSTATE PATHOLOGY
22. 2054 VALUE OF TARGETED BIOPSY IN DETECTING PROSTATE CANCER USING AN OFFICE-BASED MR-US FUSION DEVICE
23. 2003 ANTITUMOR ACTIVITY OF SUNITINIB VERSUS OTHER FDA-APPROVED TARGETED CANCER AGENTS AGAINST METASTATIC RENAL CELL CARCINOMA IN THE FIRST-LINE SETTING
24. 2002 NON-CLEAR CELL HISTOLOGY IS INDEPENDENTLY ASSOCIATED WITH POOR OUTCOMES IN THE TARGETED THERAPY ERA
25. 1475 FACTORS PREDICTIVE OF DEVELOPING COMPLICATIONS FOLLOWING PRIMARY AND SALVAGE CRYOABLATION OF THE PROSTATE
26. 979 UISS RISK STRATIFICATION CAN IDENTIFY PATIENTS LESS LIKELY TO BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA
27. 437 GAIN OF CHROMOSOME 8Q IS ASSOCIATED WITH METASTASES AND POOR SURVIVAL OF PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.